CNN — Three child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies…
Tag: Pfizer
Covid-19 booster raises antibody levels against Omicron for children ages 5 through 11, Pfizer and BioNTech say
The new data come from a small study of 140 children ages 5 through 11 who were given a third 10-microgram dose of the Pfizer-BioNTech Covid-19 vaccine at least six…
Pfizer Says Booster Strengthens Immune Response for Children 5 to 11
Several hundred children ages 5 to 11 have died of Covid since the pandemic began, according to the Centers for Disease Control and Prevention, but pediatric shots have been a…
Pfizer blood pressure medication recalled over cancer risk concerns
Accuretic and its two generic versions distributed by Greenstone — quinapril and hydrochlorothiazide tablets and quinapril HCl/hydrochlorothiazide tablets — are subject to the recall. The medications treat hypertension, which increases…
Mounting Data Shows J&J Vaccine as Effective as Pfizer and Moderna
Roughly 17 million Americans received the Johnson & Johnson Covid vaccine, only to be told later that it was the least protective of the options available in the United States.…
Pfizer CEO Says Fourth COVID-19 Vaccine Dose ‘Is Necessary’
A fourth COVID-19 vaccine shot will be necessary to prevent future coronavirus infection, Pfizer’s CEO said Sunday as the pharmaceutical company prepares to submit supporting data to the Food and…
Pfizer Shot Is Far Less Effective in 5- to 11-Year-Olds Than in Older Kids, New Data Show
The coronavirus vaccine made by Pfizer-BioNTech is much less effective in preventing infection in children ages 5 to 11 years than in older adolescents or adults, according to a large…
Omicron Helped Clarify Pfizer Vaccine Efficacy in Young Kids, Gottlieb Says
By now, the Omicron wave of the coronavirus has crested in much of the United States. But the size of the wave, which broke records for national cases and hospitalizations,…
Pfizer Asks F.D.A. to Clear 2 Vaccine Doses for Young Children as a Start
Albert Bourla, Pfizer’s chairman and chief executive, said in a statement that “ultimately, we believe that three doses of the vaccine will be needed for children 6 months through 4…